drugset / Trial / NCT06840535
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The aim of this study is to assess the safety and dosimetry of \[68Ga\]Ga-OncoACP3 in patients with prostate cancer.
Timeline
- Start
- 2025-04-08
- Primary completion
- 2025-10-03
- Completion
- 2025-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [68Ga]Ga-OncoACP3 | Diagnostic / imaging agent | — | Intravenous |